90 related articles for article (PubMed ID: 1964586)
21. Light microscopic observations of transplantable mouse hepatomas.
Leduc EH; Malick LE; Holden HE
Cancer Res; 1974 Apr; 34(4):716-21. PubMed ID: 4360836
[No Abstract] [Full Text] [Related]
22. Establishment and characterization of two cell lines derived from a single hepatocellular carcinoma containing multiploid DNA distribution.
Chiu JH; Chang HM; Kao HL; Wu LH; Lui WY
Cancer Detect Prev; 1996; 20(1):43-51. PubMed ID: 8907202
[TBL] [Abstract][Full Text] [Related]
23. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
Niwa Y; Matsumura M; Shiratori Y; Imamura M; Kato N; Shiina S; Okudaira T; Ikeda Y; Inoue T; Omata M
Hepatology; 1996 Jun; 23(6):1384-92. PubMed ID: 8675155
[TBL] [Abstract][Full Text] [Related]
24. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
25. Interstitial chromosomal deletion within 4q11-q13 in a human hepatoma cell line.
Urano Y; Watanabe K; Lin CC; Hino O; Tamaoki T
Cancer Res; 1991 Mar; 51(5):1460-4. PubMed ID: 1847664
[TBL] [Abstract][Full Text] [Related]
26. [Establishment and biological characteristics of the nude mice xenograft model from human hepatocellular carcinoma].
Liu X; Hu J; Cui H; Yang X; Li S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):98-103. PubMed ID: 7544697
[TBL] [Abstract][Full Text] [Related]
27. Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells.
Kishima Y; Yoshida K; Enomoto H; Yamamoto M; Kuroda T; Okuda Y; Uyama H; Nakamura H
Hepatogastroenterology; 2002; 49(48):1639-44. PubMed ID: 12397753
[TBL] [Abstract][Full Text] [Related]
28. Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma.
Torimura T; Ueno T; Kin M; Taniguchi E; Nakamura T; Inoue K; Sakata R; Hashimoto O; Sakamoto M; Ohira H; Kumashiro R; Sata M; Yano H; Kojiro M; Veitonmaki N; Cao Y
Gastroenterology; 2006 Apr; 130(4):1301-10. PubMed ID: 16618420
[TBL] [Abstract][Full Text] [Related]
29. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL
Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043
[TBL] [Abstract][Full Text] [Related]
30. Genetic alterations in doxorubicin-resistant hepatocellular carcinoma cells: a combined study of spectral karyotyping, positional expression profiling and candidate genes.
Hu Y; Pang E; Lai PB; Squire JA; MacGregor PF; Beheshti B; Albert M; Leung TW; Wong N
Int J Oncol; 2004 Nov; 25(5):1357-64. PubMed ID: 15492826
[TBL] [Abstract][Full Text] [Related]
31. A new human pleomorphic hepatocellular carcinoma cell line, KYN-2.
Yano H; Maruiwa M; Murakami T; Fukuda K; Ito Y; Sugihara S; Kojiro M
Acta Pathol Jpn; 1988 Aug; 38(8):953-66. PubMed ID: 2847482
[TBL] [Abstract][Full Text] [Related]
32. A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: implication for immunotherapy of human hepatocellular carcinoma.
Atarashi Y; Yasumura S; Nambu S; Yoshio Y; Murakami J; Takahara T; Higuchi K; Watanabe A; Miyata K; Kato M
Hepatology; 1998 Jul; 28(1):57-67. PubMed ID: 9657097
[TBL] [Abstract][Full Text] [Related]
33. Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein.
Watkins PJ; Condreay JP; Huber BE; Jacobs SJ; Adams DJ
Cancer Res; 1996 Mar; 56(5):1063-7. PubMed ID: 8640762
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor II regulation of gene expression in rat and human hepatomas.
Zvibel I; Brill S; Reid LM
J Cell Physiol; 1995 Jan; 162(1):36-43. PubMed ID: 7529237
[TBL] [Abstract][Full Text] [Related]
35. [Establishment and characterization of a human gall bladder carcinoma cell line NOZ].
Homma S; Hasumura S; Nagamori S; Kameda H
Hum Cell; 1988 Mar; 1(1):95-7. PubMed ID: 3154020
[TBL] [Abstract][Full Text] [Related]
36. [RNA interference targeting focal adhesion kinase inhibited the growth of human hepatocellular carcinoma sk-hep-1].
Xu WJ; Zhang S; Zhang N; Yang Y; Wei YQ; Deng HX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):455-60. PubMed ID: 21866625
[TBL] [Abstract][Full Text] [Related]
37. [Growth pattern and metastatic behaviour of orthotopically metastatic model of human hepatocellular carcinoma in nude mice].
Sun F; Tang Z; Liu K
Zhonghua Yi Xue Za Zhi; 1995 Nov; 75(11):673-5, 710. PubMed ID: 8697088
[TBL] [Abstract][Full Text] [Related]
38. A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping.
Wong N; Lai P; Pang E; Leung TW; Lau JW; Johnson PJ
Hepatology; 2000 Nov; 32(5):1060-8. PubMed ID: 11050057
[TBL] [Abstract][Full Text] [Related]
39. A new human hepatocellular carcinoma cell line (KYN-1) with a transformation to adenocarcinoma.
Yano H; Kojiro M; Nakashima T
In Vitro Cell Dev Biol; 1986 Nov; 22(11):637-46. PubMed ID: 2430933
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a cell line (HCC-M) from a human hepatocellular carcinoma.
Watanabe T; Morizane T; Tsuchimoto K; Inagaki Y; Munakata Y; Nakamura T; Kumagai N; Tsuchiya M
Int J Cancer; 1983 Aug; 32(2):141-6. PubMed ID: 6307892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
